CYP17A1 and breast cancer: Here, in the present study, we identified the diosgenin to regulate the prolactin signaling pathway via the regulation of three genes i.e., STAT3, CYP17A1, and SRC which could avoid estrogen or progestogen receptor-mediated breast cancer progression.